Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer
Preprint
Abstract
Background and Aims: Inflammatory bowel disease is associated with an increased risk of skin cancer. The aims of this study were to determine whether genomic variants associated with IBD susceptibility are also associated with skin cancer susceptibility and if such risk is augmented by the use of immune-suppressive therapy. Methods: The discovery cohort included participants in the UK Biobank (n=408,381). The validation cohort included participants in the Michigan Genomics Initiative (n=51,405). The primary outcome of interest was skin cancer, sub-grouped into non-melanoma (NMSC) and melanoma skin cancers (MSC). Multivariable logistic regression was performed to identify genomic predictors of skin malignancy. Validated SNPs were evaluated for effect modification by immune-suppressive medication. Results: The discovery cohort included 11,079 cases of NMSC and 2,054 cases of MSC. The validation cohort included 7,334 cases of NMSC and 3,304 cases of MSC. Thirty variants were associated with risk of NMSC in the discovery cohort, of which six replicated in the validation cohort [Increased risk: rs7773324-A ( DUSP22; IRF4 ), rs2476601-G ( PTPN22 ), rs1847472-C ( BACH2 ), rs72810983-A ( CPEB4 ); Decreased risk: rs6088765-G ( PROCR; MMP24 ), rs11229555-G ( ZFP91-CNTF; GLYAT )]. Twelve variants were associated with risk of MSC in the discovery cohort, of which three replicated in the validation cohort (Increased risk: rs61839660-T ( IL2RA ); Decreased risk: rs17391694-C ( GIPC2; MGC27382 ), rs6088765-G ( PROCR; MMP24 )]. No effect modification was observed. Conclusion: The results of this study highlight shared genetic susceptibility across IBD and skin cancer, with increased risk of NMSC in those who carry risk variants in IRF4, PTPN22, CPEB4 , and BACH2 and increased risk of MSC in those who carry a risk variant in IL2RA .Keywords
All Related Versions
- Published version: Inflammatory Bowel Diseases, 28 (11), 1667.
This publication has 42 references indexed in Scilit:
- Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian PopulationGastroenterology, 2020
- Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based StudyClinical Gastroenterology and Hepatology, 2017
- Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012JAMA Dermatology, 2015
- Malignancies in inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2014
- Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2014
- Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control StudyClinical Gastroenterology and Hepatology, 2013
- Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel DiseaseGastroenterology, 2012
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel DiseaseGastroenterology, 2011
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2010
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisGastroenterology, 2004